What is OptimizeRx's EBITDA?

OptimizeRx (OPRX) reported EBITDA of $1.46M in Q1 2026.

How has OptimizeRx's EBITDA changed year-over-year?

OptimizeRx's EBITDA increased by 244.8% year-over-year, from -$1.01M to $1.46M.

What is the long-term trend for OptimizeRx's EBITDA?

Over 3 years (2021 to 2025), OptimizeRx's EBITDA has grown at a 90.6% compound annual growth rate (CAGR), from $2.32M to $16.03M.

What does EBITDA mean?

Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

OptimizeRx OPRX EBITDA

Discontinued — last reported Q1 '26

EBITDA at other companies

PhreesiaPHR

$16.7M+365%

DoximityDOCS

$28.96M-43.8%

GoodRx Holdings, Inc.GDRX

$35.8M-19.2%

PubMaticPUBM

-$5.29M-2,228%

Spectral AI, Inc.MDAI

-$1.94M-117%

Veeva SystemsVEEV

——

Other financials

Income statement

See full

Revenue$19.8M-9.5%

Gross profit$14.9M+11.9%

Operating income$396.0K+119%

Net income-$495.0K+77.5%

EPS (diluted)-$0.03+75.0%

Balance sheet

See full

Cash & equivalents$20.2M+21.7%

Total debt$23.7M-27.7%

Total equity$129.6M+11.5%

Total assets$167.3M-0.3%

Cash flow

See full

Operating cash flow-$467.0K-112%

CapEx$21.0K-22.2%

Free cash flow-$488.0K-113%

Valuation

See full

Market cap$107.34M-54.1%

Enterprise value$110.88M-55.0%

P/E15.7×—

P/S1×-1.2×

Profitability

See full

Gross margin70%+14.1pp

Operating margin13.2%—

Net margin6.4%+3.6pp

FCF margin13.4%+4.8pp

Returns & leverage

See full

Return on equity5.6%+3.3pp

Debt / equity0.2×-0.1×

Current ratio5.4×+2.6×

Where this comes from

Calculated from OptimizeRx’s reported figures.

$396.0Kebit+

$1.1MDepreciation Depletion & Amortization

=$1.46M

The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about OptimizeRx's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OptimizeRx's EBITDA?: OptimizeRx (OPRX) reported EBITDA of $1.46M in Q1 2026.
How has OptimizeRx's EBITDA changed year-over-year?: OptimizeRx's EBITDA increased by 244.8% year-over-year, from -$1.01M to $1.46M.
What is the long-term trend for OptimizeRx's EBITDA?: Over 3 years (2021 to 2025), OptimizeRx's EBITDA has grown at a 90.6% compound annual growth rate (CAGR), from $2.32M to $16.03M.
What does EBITDA mean?: Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.